BRIEF-Luye Pharma Group Granted Exclusive Rights To Commercialize New Drug In Four European Countries

Reuters · 03/16/2021 10:33
BRIEF-Luye Pharma Group Granted Exclusive Rights To Commercialize New Drug In Four European Countries

- Luye Pharma Group Ltd 2186.HK:

  • GRANTED EXCLUSIVE RIGHTS TO COMMERCIALIZE NEW DRUG RIVASTIGMINE MD IN FOUR EUROPEAN COUNTRIES TO ITALFARMACO

Source text for Eikon: nHKS9g10g0

Further company coverage: 2186.HK


((Reuters.Briefs@thomsonreuters.com;))